Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance

Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance(IR). Macrophages infiltrate the adipose tissue(AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltrat...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of diabetes Vol. 8; no. 3; pp. 97 - 103
Main Authors Abe, Tomoki, Hirasaka, Katsuya, Nikawa, Takeshi
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 15.03.2017
Subjects
Online AccessGet full text
ISSN1948-9358
1948-9358
DOI10.4239/wjd.v8.i3.97

Cover

Abstract Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance(IR). Macrophages infiltrate the adipose tissue(AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4(TLR4) and induce inflammatory responses in AT macrophages(ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b(Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs.
AbstractList Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR). Macrophages infiltrate the adipose tissue (AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4 (TLR4) and induce inflammatory responses in AT macrophages (ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b (Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs.
Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR). Macrophages infiltrate the adipose tissue (AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4 (TLR4) and induce inflammatory responses in AT macrophages (ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b (Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs.Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR). Macrophages infiltrate the adipose tissue (AT) of obese individuals and cause chronic low-level inflammation associated with IR. Macrophage infiltration is regulated by the chemokines that are released from hypertrophied adipocytes and the immune cells in AT. Saturated fatty acids are recognized by toll-like receptor 4 (TLR4) and induce inflammatory responses in AT macrophages (ATMs). The inflammatory cytokines that are released from activated ATMs promote IR in peripheral organs, such as the liver, skeletal muscle and AT. Therefore, ATM activation is a therapeutic target for IR in obesity. The ubiquitin ligase Casitas b-lineage lymphoma-b (Cbl-b) appears to potently suppress macrophage migration and activation. Cbl-b is highly expressed in leukocytes and negatively regulates signals associated with migration and activation. Cbl-b deficiency enhances ATM accumulation and IR in aging- and diet-induced obese mice. Cbl-b inhibits migration-related signals and SFA-induced TLR4 signaling in ATMs. Thus, targeting Cbl-b may be a potential therapeutic strategy to reduce the IR induced by ATM activation. In this review, we summarize the regulatory functions of Cbl-b in ATMs.
Author Tomoki Abe Katsuya Hirasaka Takeshi Nikawa
AuthorAffiliation Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School;Graduate School of Fisheries Science and Environmental Studies, Nagasaki University
Author_xml – sequence: 1
  givenname: Tomoki
  surname: Abe
  fullname: Abe, Tomoki
– sequence: 2
  givenname: Katsuya
  surname: Hirasaka
  fullname: Hirasaka, Katsuya
– sequence: 3
  givenname: Takeshi
  surname: Nikawa
  fullname: Nikawa, Takeshi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28344752$$D View this record in MEDLINE/PubMed
BookMark eNp1UU1r3DAQFSWhSdO99Rz22EO8sfWtS6AsaRsayCU5C8ke72qxpY3ldei_77TZLkkgQjAj9Oa9x5tP5CimCIR8qcoFp8xcPm2axaQXgS2M-kBOK8N1YZjQRy_6EzLLeVPi4UJKZj6SE6oZ50rQU_LrJk6pm6CHOM5TO1_6rvBFD01wIzTz3tVD2q7dCuYhunoMkxtDivjAm3cd1gFyyKOLNXwmx63rMsz29Yw8fL--X_4sbu9-3Cy_3RY1l3osRNM2SlIlZCu8UACVlJp6akrBS2Og8dx7T71iDddV2yr0DaVCy8ZJAMrOyNUz73bn0WmN1gfX2e0Qejf8tskF-_onhrVdpckKxrWkAgm-7gmG9LiDPNo-5Bq6zkVIu2wrrSvODRUlQs9fah1E_ieIgItnAAaV8wDtAVKV9u-OLO7ITtoGZo1COH0Dr8P4L1N0Grr3hth-aJ3i6jHE1UFEK4WhSiNKrrkRgmtRYafR-h9MbabW
CitedBy_id crossref_primary_10_2147_DMSO_S273780
crossref_primary_10_1016_j_bbrc_2021_07_093
crossref_primary_10_1186_s12967_021_03069_w
crossref_primary_10_1080_13543776_2024_2412567
crossref_primary_10_3390_ijms21176335
crossref_primary_10_1155_2022_3968494
crossref_primary_10_1186_s12964_021_00735_w
crossref_primary_10_3389_fnut_2024_1445080
crossref_primary_10_3389_fimmu_2024_1297893
crossref_primary_10_3390_ijms241310419
crossref_primary_10_1126_sciadv_abd3359
Cites_doi 10.1038/ng.584
10.1016/j.cell.2007.08.002
10.2337/db06-1027
10.1074/jbc.M606781200
10.1038/18050
10.1038/ni1299
10.1084/jem.20021686
10.1016/j.metabol.2013.06.008
10.5551/jat.3368
10.2337/db06-1768
10.1038/nm1607
10.1007/978-1-4419-1603-7_6
10.1172/JCI24335
10.1073/pnas.1110712108
10.1038/ni.1908
10.1074/jbc.M706762200
10.1007/s00125-012-2710-2
10.4172/2155-6156.1000364
10.1016/j.molcel.2010.10.004
10.1189/jlb.3HI0115-018R
10.1016/j.yexcr.2005.07.015
10.1038/nm1185
10.1038/ng927
10.1016/j.imbio.2015.06.016
10.1038/nm.4141
10.1111/j.1476-5381.2012.02097.x
10.1155/2015/340520
10.1111/j.1365-2567.2008.02892.x
10.1189/jlb.1012487
10.1161/01.ATV.0000251 608.09329.9a
10.1038/35067100
10.1172/JCI28898
10.1161/01.CIR.0000 091339.70120.53
10.1038/nm.1964
10.1016/S1074-7613(00)80273-3
10.1097/MOL.0b013e32832fa5c4
10.1172/JCI19246
10.1016/j.cmet.2007. 09.011
10.1038/sj.onc.1202499
10.2337/db09-1403
10.1126/science.1227568
10.1038/nm.2851
10.1016/j.cmet.2009.09.006
10.1016/S1097-2765(00)80231-2
10.1038/nri722
10.2337/db11-1300
10.2337/db12-0677
10.1146/annurev.biochem.70.1.503
10.1038/sj.onc.1202411
10.1038/ni1066
10.4049/jimmunol.1500859
10.1016/j.bbrc.2008.01.032
10.1016/S0070-2153(05)68005-2
10.1128/MCB.01347-08
10.1096/fj.12-205583
10.1371/journal.pone.0088704
10.1084/jem.20151932
10.4049/jimmunol.174.3.1472
10.1016/j.bbadis.2013.05.017
10.1038/ni855
ContentType Journal Article
Copyright The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017
Copyright_xml – notice: The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017
DBID 2RA
92L
CQIGP
~WA
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.4239/wjd.v8.i3.97
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库- 镜像站点
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance
EISSN 1948-9358
EndPage 103
ExternalDocumentID PMC5348625
28344752
10_4239_wjd_v8_i3_97
87746869504849554851484850
Genre Journal Article
Review
GroupedDBID ---
2RA
53G
5VR
8WL
92L
AAKDD
ADBBV
AFUIB
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CCEZO
CHBEP
CIEJG
CQIGP
CW9
DIK
FA0
GX1
HYE
M~E
OK1
RNS
RPM
~WA
AAYXX
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c468t-5dfd762756f5b57ee16682b29054099edb4bbb2b73d481ff7045e078349a6ee23
ISSN 1948-9358
IngestDate Thu Aug 21 18:04:57 EDT 2025
Fri Jul 11 02:49:20 EDT 2025
Thu Jan 02 22:22:01 EST 2025
Tue Jul 01 03:34:00 EDT 2025
Thu Apr 24 22:58:32 EDT 2025
Wed Feb 14 10:03:13 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Keywords Obesity
Insulin resistance
Casitas b-lineage lymphoma-b
Toll-like receptor 4
Macrophage
Language English
License This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c468t-5dfd762756f5b57ee16682b29054099edb4bbb2b73d481ff7045e078349a6ee23
Notes Tomoki Abe;Katsuya Hirasaka;Takeshi Nikawa;Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School;Graduate School of Fisheries Science and Environmental Studies, Nagasaki University
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Telephone: +81-88-6339248 Fax: +81-88-6337086
Author contributions: Abe T generated the figures and wrote the manuscript; Hirasaka K and Nikawa T specified the aims of the editorial and assisted in writing the manuscript.
Correspondence to: Takeshi Nikawa, MD, PhD, Professor, Department of Nutritional Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan. nikawa@tokushima-u.ac.jp
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5348625
PMID 28344752
PQID 1881449250
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5348625
proquest_miscellaneous_1881449250
pubmed_primary_28344752
crossref_primary_10_4239_wjd_v8_i3_97
crossref_citationtrail_10_4239_wjd_v8_i3_97
chongqing_primary_87746869504849554851484850
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-03-15
PublicationDateYYYYMMDD 2017-03-15
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of diabetes
PublicationTitleAlternate World Journal of Diabetes
PublicationYear 2017
Publisher Baishideng Publishing Group Inc
Publisher_xml – name: Baishideng Publishing Group Inc
References ref13
ref57
ref12
ref56
ref15
ref59
ref14
ref58
ref53
ref52
ref11
ref55
ref10
ref54
ref17
ref16
ref19
ref18
ref51
ref50
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref2
ref1
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref60
ref61
12118252 - Nat Genet. 2002 Aug;31(4):391-4
22618766 - Diabetes. 2012 Jun;61(6):1315-22
17053832 - J Clin Invest. 2006 Nov;116(11):3015-25
22983634 - Diabetologia. 2012 Dec;55(12):3350-8
20103702 - Diabetes. 2010 Apr;59(4):916-25
26180583 - Oxid Med Cell Longev. 2015;2015:340520
10086340 - Oncogene. 1999 Mar 11;18(10 ):1855-66
20453840 - Nat Genet. 2010 Jun;42(6):495-7
22842477 - Nat Med. 2012 Aug;18(8):1279-85
18624726 - Immunology. 2009 Feb;126(2):233-45
26162692 - Immunobiology. 2015 Nov;220(11):1246-54
25934927 - J Leukoc Biol. 2015 Oct;98(4):467-77
17601987 - Diabetes. 2007 Oct;56(10 ):2511-22
23707515 - Biochim Biophys Acta. 2014 Mar;1842(3):446-62
10635327 - Mol Cell. 1999 Dec;4(6):1029-40
17618294 - Nat Med. 2007 Aug;13(8):920-6
20639876 - Nat Immunol. 2010 Aug;11(8):734-42
15107846 - Nat Immunol. 2004 May;5(5):495-502
16341265 - J Clin Invest. 2006 Jan;116(1):115-24
16415872 - Nat Immunol. 2006 Feb;7(2):148-55
17392283 - J Biol Chem. 2007 Jun 1;282(22):16042-53
14517163 - Circulation. 2003 Oct 14;108(15):1822-30
20179360 - J Atheroscler Thromb. 2010 Mar 31;17(3):219-28
17259398 - Diabetes. 2007 Feb;56(2):506-12
16124998 - Curr Top Dev Biol. 2005;68:123-48
15661906 - J Immunol. 2005 Feb 1;174(3):1472-8
19546233 - Mol Cell Biol. 2009 Sep;29(17 ):4798-811
12415267 - Nat Immunol. 2002 Dec;3(12 ):1192-9
19883619 - Cell Metab. 2009 Nov;10(5):419-29
11910892 - Nat Rev Immunol. 2002 Feb;2(2):106-15
22776094 - Br J Pharmacol. 2012 Nov;167(5):990-9
26392463 - J Immunol. 2015 Nov 1;195(9):4415-25
19633658 - Nat Med. 2009 Aug;15(8):914-20
12771181 - J Exp Med. 2003 Jun 2;197(11):1511-24
20965425 - Mol Cell. 2010 Oct 22;40(2):323-32
17803912 - Cell. 2007 Sep 7;130(5):906-17
8986718 - Immunity. 1996 Dec;5(6):591-604
16137676 - Exp Cell Res. 2005 Nov 1;310(2):303-10
24551137 - PLoS One. 2014 Feb 13;9(2):e88704
23325923 - J Leukoc Biol. 2013 Apr;93(4):611-22
27428899 - Nat Med. 2016 Aug;22(8):906-14
23223452 - Science. 2013 Jan 11;339(6116):218-22
19625959 - Curr Opin Lipidol. 2009 Oct;20(5):379-85
14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
20665200 - Adv Exp Med Biol. 2010;667:59-68
10078535 - Nature. 1999 Mar 4;398(6722):84-90
11283727 - Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307
17983584 - Cell Metab. 2007 Nov;6(5):386-97
11395416 - Annu Rev Biochem. 2001;70:503-33
23953944 - Metabolism. 2013 Nov;62(11):1623-32
17916553 - J Biol Chem. 2007 Nov 30;282(48):35279-92
18201552 - Biochem Biophys Res Commun. 2008 Mar 28;368(1):37-42
10022120 - Oncogene. 1999 Feb 4;18(5):1147-56
22562833 - FASEB J. 2012 Aug;26(8):3282-91
15685170 - Nat Med. 2005 Feb;11(2):191-8
27432944 - J Exp Med. 2016 Jul 25;213(8):1555-70
22158902 - Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20579-84
23349502 - Diabetes. 2013 Jun;62(6):1957-69
17082484 - Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91
References_xml – ident: ref1
– ident: ref21
  doi: 10.1038/ng.584
– ident: ref58
  doi: 10.1016/j.cell.2007.08.002
– ident: ref22
  doi: 10.2337/db06-1027
– ident: ref55
  doi: 10.1074/jbc.M606781200
– ident: ref15
  doi: 10.1038/18050
– ident: ref50
  doi: 10.1038/ni1299
– ident: ref14
  doi: 10.1084/jem.20021686
– ident: ref40
  doi: 10.1016/j.metabol.2013.06.008
– ident: ref43
  doi: 10.5551/jat.3368
– ident: ref35
  doi: 10.2337/db06-1768
– ident: ref53
  doi: 10.1038/nm1607
– ident: ref24
  doi: 10.1007/978-1-4419-1603-7_6
– ident: ref38
  doi: 10.1172/JCI24335
– ident: ref18
  doi: 10.1073/pnas.1110712108
– ident: ref8
  doi: 10.1038/ni.1908
– ident: ref31
  doi: 10.1074/jbc.M706762200
– ident: ref39
  doi: 10.1007/s00125-012-2710-2
– ident: ref59
  doi: 10.4172/2155-6156.1000364
– ident: ref2
  doi: 10.1016/j.molcel.2010.10.004
– ident: ref41
  doi: 10.1189/jlb.3HI0115-018R
– ident: ref44
  doi: 10.1016/j.yexcr.2005.07.015
– ident: ref32
  doi: 10.1038/nm1185
– ident: ref19
  doi: 10.1038/ng927
– ident: ref57
  doi: 10.1016/j.imbio.2015.06.016
– ident: ref10
  doi: 10.1038/nm.4141
– ident: ref56
  doi: 10.1111/j.1476-5381.2012.02097.x
– ident: ref3
  doi: 10.1155/2015/340520
– ident: ref28
  doi: 10.1111/j.1365-2567.2008.02892.x
– ident: ref46
  doi: 10.1189/jlb.1012487
– ident: ref26
  doi: 10.1161/01.ATV.0000251 608.09329.9a
– ident: ref12
  doi: 10.1038/35067100
– ident: ref25
  doi: 10.1172/JCI28898
– ident: ref60
  doi: 10.1161/01.CIR.0000 091339.70120.53
– ident: ref7
  doi: 10.1038/nm.1964
– ident: ref45
  doi: 10.1016/S1074-7613(00)80273-3
– ident: ref54
  doi: 10.1097/MOL.0b013e32832fa5c4
– ident: ref23
  doi: 10.1172/JCI19246
– ident: ref34
  doi: 10.1016/j.cmet.2007. 09.011
– ident: ref13
  doi: 10.1038/sj.onc.1202499
– ident: ref42
  doi: 10.2337/db09-1403
– ident: ref33
  doi: 10.1126/science.1227568
– ident: ref29
  doi: 10.1038/nm.2851
– ident: ref27
  doi: 10.1016/j.cmet.2009.09.006
– ident: ref16
  doi: 10.1016/S1097-2765(00)80231-2
– ident: ref37
  doi: 10.1038/nri722
– ident: ref5
  doi: 10.2337/db11-1300
– ident: ref36
  doi: 10.2337/db12-0677
– ident: ref11
  doi: 10.1146/annurev.biochem.70.1.503
– ident: ref17
  doi: 10.1038/sj.onc.1202411
– ident: ref49
  doi: 10.1038/ni1066
– ident: ref52
  doi: 10.4049/jimmunol.1500859
– ident: ref20
  doi: 10.1016/j.bbrc.2008.01.032
– ident: ref4
  doi: 10.1016/S0070-2153(05)68005-2
– ident: ref61
  doi: 10.1128/MCB.01347-08
– ident: ref51
  doi: 10.1096/fj.12-205583
– ident: ref30
  doi: 10.1371/journal.pone.0088704
– ident: ref9
  doi: 10.1084/jem.20151932
– ident: ref48
  doi: 10.4049/jimmunol.174.3.1472
– ident: ref6
  doi: 10.1016/j.bbadis.2013.05.017
– ident: ref47
  doi: 10.1038/ni855
– reference: 17983584 - Cell Metab. 2007 Nov;6(5):386-97
– reference: 12415267 - Nat Immunol. 2002 Dec;3(12 ):1192-9
– reference: 16137676 - Exp Cell Res. 2005 Nov 1;310(2):303-10
– reference: 23707515 - Biochim Biophys Acta. 2014 Mar;1842(3):446-62
– reference: 15661906 - J Immunol. 2005 Feb 1;174(3):1472-8
– reference: 11395416 - Annu Rev Biochem. 2001;70:503-33
– reference: 8986718 - Immunity. 1996 Dec;5(6):591-604
– reference: 17392283 - J Biol Chem. 2007 Jun 1;282(22):16042-53
– reference: 15107846 - Nat Immunol. 2004 May;5(5):495-502
– reference: 12118252 - Nat Genet. 2002 Aug;31(4):391-4
– reference: 17618294 - Nat Med. 2007 Aug;13(8):920-6
– reference: 20103702 - Diabetes. 2010 Apr;59(4):916-25
– reference: 10635327 - Mol Cell. 1999 Dec;4(6):1029-40
– reference: 11910892 - Nat Rev Immunol. 2002 Feb;2(2):106-15
– reference: 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
– reference: 20179360 - J Atheroscler Thromb. 2010 Mar 31;17(3):219-28
– reference: 22983634 - Diabetologia. 2012 Dec;55(12):3350-8
– reference: 10022120 - Oncogene. 1999 Feb 4;18(5):1147-56
– reference: 12771181 - J Exp Med. 2003 Jun 2;197(11):1511-24
– reference: 19633658 - Nat Med. 2009 Aug;15(8):914-20
– reference: 10078535 - Nature. 1999 Mar 4;398(6722):84-90
– reference: 19546233 - Mol Cell Biol. 2009 Sep;29(17 ):4798-811
– reference: 17082484 - Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91
– reference: 20639876 - Nat Immunol. 2010 Aug;11(8):734-42
– reference: 23325923 - J Leukoc Biol. 2013 Apr;93(4):611-22
– reference: 18624726 - Immunology. 2009 Feb;126(2):233-45
– reference: 22562833 - FASEB J. 2012 Aug;26(8):3282-91
– reference: 27432944 - J Exp Med. 2016 Jul 25;213(8):1555-70
– reference: 17259398 - Diabetes. 2007 Feb;56(2):506-12
– reference: 11283727 - Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307
– reference: 17053832 - J Clin Invest. 2006 Nov;116(11):3015-25
– reference: 20665200 - Adv Exp Med Biol. 2010;667:59-68
– reference: 23349502 - Diabetes. 2013 Jun;62(6):1957-69
– reference: 14517163 - Circulation. 2003 Oct 14;108(15):1822-30
– reference: 23953944 - Metabolism. 2013 Nov;62(11):1623-32
– reference: 24551137 - PLoS One. 2014 Feb 13;9(2):e88704
– reference: 22842477 - Nat Med. 2012 Aug;18(8):1279-85
– reference: 17916553 - J Biol Chem. 2007 Nov 30;282(48):35279-92
– reference: 18201552 - Biochem Biophys Res Commun. 2008 Mar 28;368(1):37-42
– reference: 22618766 - Diabetes. 2012 Jun;61(6):1315-22
– reference: 22158902 - Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20579-84
– reference: 16415872 - Nat Immunol. 2006 Feb;7(2):148-55
– reference: 20965425 - Mol Cell. 2010 Oct 22;40(2):323-32
– reference: 23223452 - Science. 2013 Jan 11;339(6116):218-22
– reference: 22776094 - Br J Pharmacol. 2012 Nov;167(5):990-9
– reference: 10086340 - Oncogene. 1999 Mar 11;18(10 ):1855-66
– reference: 17803912 - Cell. 2007 Sep 7;130(5):906-17
– reference: 26392463 - J Immunol. 2015 Nov 1;195(9):4415-25
– reference: 26180583 - Oxid Med Cell Longev. 2015;2015:340520
– reference: 25934927 - J Leukoc Biol. 2015 Oct;98(4):467-77
– reference: 19883619 - Cell Metab. 2009 Nov;10(5):419-29
– reference: 15685170 - Nat Med. 2005 Feb;11(2):191-8
– reference: 27428899 - Nat Med. 2016 Aug;22(8):906-14
– reference: 19625959 - Curr Opin Lipidol. 2009 Oct;20(5):379-85
– reference: 16341265 - J Clin Invest. 2006 Jan;116(1):115-24
– reference: 20453840 - Nat Genet. 2010 Jun;42(6):495-7
– reference: 17601987 - Diabetes. 2007 Oct;56(10 ):2511-22
– reference: 16124998 - Curr Top Dev Biol. 2005;68:123-48
– reference: 26162692 - Immunobiology. 2015 Nov;220(11):1246-54
SSID ssj0000456639
Score 2.0631907
SecondaryResourceType review_article
Snippet Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance(IR)....
Aging and overnutrition cause obesity in rodents and humans. It is well-known that obesity causes various diseases by producing insulin resistance (IR)....
SourceID pubmedcentral
proquest
pubmed
crossref
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 97
SubjectTerms Minireviews
Title Involvement of Cbl-b-mediated macrophage inactivation in insulin resistance
URI http://lib.cqvip.com/qk/71418X/201703/87746869504849554851484850.html
https://www.ncbi.nlm.nih.gov/pubmed/28344752
https://www.proquest.com/docview/1881449250
https://pubmed.ncbi.nlm.nih.gov/PMC5348625
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSIgXxDcdHwoSPEFK49iJ_YimjQFbeUmlvll246yhW8LWdBP89ZztfI4-DF6s1HFty3e-3J3vfkbo7YRpokIufUkW1CdYBbDnzCk85pmikqjAJtIeT6PDGfk6p_PmovE6u6RS48XvrXkl_0NVqAO6mizZf6Bs2ylUwDPQF0qgMJQ3ovGXAoSLBfy25_l76tRXvs0FMXrkmTTXcy1NUE5emPwF5301Ho4mAh1sbaM_NoSvlVQXYNPDlGgctN1ZkcPqLc_KVd45ry_kWq7qFLNqvfnVSvxpvpJX9kUiV3q9zPu-Bvh-mcA12hOPnIB4DB3Y-lhvqatlKuuxTtiTjy4W97rYNiCEsNZXP9LxJRvn4dg1G6JjT7-Lg9nRkUj258ltdAfHsT2W_zwPWp-aUU8je3lcOymX62AG-Njv3iBpLMvi5Bz0g6FG8peZcT1atqd-JA_Q_dpu8D45JniIbuniEbp7XEdGPEbferzglZk35AWv4wWvzwvww6t5wet44QmaHewne4d-fVGGvyARq3yaZmlsgfwzqmisdRBFDCvMjT7OuU4VUUphFYcpYUGWxbBQ2pzfEi4jrXH4FO0UZaGfI4-noLLFOI01C0g2wQqWNM0iPsmIhn-rEfrQLpz46QBRBOxumEfEKXwOwOAGIxjUcAblZITeN2srFjXovLn75FSA8WmoIoAq4pKJPBQ8HqF3beum7-3t3jRkEiANzRGXLHS5WYuAwbQN3iaM_MyRre0JM4tuiUcoHhC0bWCQ1odvinxpEddpSMDyp7s3GPcFutftnJdop7rY6Fegt1bqtWXWP43Um-4
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+Cbl-b-mediated+macrophage+inactivation+in+insulin+resistance&rft.jtitle=World+journal+of+diabetes&rft.au=Abe%2C+Tomoki&rft.au=Hirasaka%2C+Katsuya&rft.au=Nikawa%2C+Takeshi&rft.date=2017-03-15&rft.issn=1948-9358&rft.eissn=1948-9358&rft.volume=8&rft.issue=3&rft.spage=97&rft_id=info:doi/10.4239%2Fwjd.v8.i3.97&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F71418X%2F71418X.jpg